Acta Scientific Ophthalmology (ASOP)

Research Article Volume 3 Issue 2

Efficacy of Thermo Mechanical Pulsations in Management of Meibomien Gland Dysfunction: A Comparative Study

Mohammed Abdelmaaboud Radwan1*, Omnia M Sherif1 and Tageldin M Othman2

11Lecturer of Ophthalmology Faculty of Medicine Cairo University, Cairo, Egypt
2Lecturer of Ophthalmology Faculty of Medicine, Aswan University, Aswan, Egypt

*Corresponding Author: Mohammed Abdelmaaboud Radwan, Lecturer (s) of Ophthalmology Faculty of Medicine Cairo University, Cairo, Egypt.

Received: January 19, 2020; Published: January 29, 2020



Objectives: To evaluate the efficacy of thermo mechanical pulsations in the management of meibomian gland dysfunction.

Materials and Methods: Fifty-two adult patients of dry eye clinic at Elite Hospital Riyadh, Saudi Arabia with established diagnosis of meibomian gland dysfunction were recruited between September 2016 and January 2018. All patients had a detailed past ocular and systemic history and full ophthalmological examination. If one eye was eligible for treatment this eye would be selected for Li pi Flow treatment and if both eyes were eligible, one eye was randomized to receive the thermal pulsation (Li pi Flow) treatment while continuing the usual treatment of lid hygiene, lubricant eye drops in the other eye.

Results: From the 52 patients who were eligible for the treatment at least in one eye 31 (59.6%) were females while only 21 (40.4%) were males; with mean ±standard deviation (SD) age 49.9 ± 6.0 range 39 to 61 years. The mean ± SD preoperative SPEED score was 11.4 ± 1.5 and showed reduction in the first postoperative assessment (2 weeks) to 9.2 ± 1.4 (p < 0.001). In control group: the mean ± SD SPEED score was 13.2 ± 3.7, with first postoperative mean ± SD of SPEED score being slightly higher 14.5 ± 3.8, which did not reach statistical significance. (p = 0.065).

Conclusion: There exists a significant subjective improvement noted by SPEED score as well as significant drop of frequency of lubricant eye drop needed to be used to alleviate the dry eye symptoms.

Keywords:Meibomian Gland Dysfunction; Dry Eyes; Li pi flow Thermal Pulsation; Saudi Arabia



  1. Hom MM., et al. “Prevalence of Meibomian gland dysfunction”. Optometry and Vision Science 67.09 (1990): 710-712.
  2. Horwath-Winter J., et al. “Evaluation of the clinical course of dry eye syndrome”. Arch Ophthalmology 121.10 (2003): 1364-1368.
  3. Jie Y., et al. “Prevalence of dry eye among adult Chinese in the Beijing Eye Study”. Eye (Lond) 23.3 (2009): 688-693.
  4. Lekhanont K., et al. “Prevalence of dry eye in Bangkok, Thailand”. Cornea 25.12 (2006):1162-1167.
  5. Lemp MA., et al. “Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study”. Cornea 31.5 (2012): 472-478.
  6. Lin PY., et al. “Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study”. Ophthalmology 110.6 (2003):1096-1101.
  7. McCarty CA., et al. “The epidemiology of dry eye in Melbourne, Australia”. Ophthalmology 105.6 (1998): 1114-1119.
  8. Schein OD., et al. “Prevalence of dry eye among the elderly”. American Journal of Ophthalmology 124.6 (1997): 723-728.
  9. Shimazaki J., et al. “Meibomian gland dysfunction in patients with Sjogren syndrome”. Ophthalmology 105.8 (1998): 1485-1488.
  10. Shimazaki J., et al. “Ocular surface changes and discomfort in patients with meibomian gland dysfunction”. Arch Ophthalmology 113.10 (1995): 1266-1270.
  11. Uchino M., et al. “The features of dry eye disease in a Japanese elderly population”. Optometry and Vision Science 83.11 (2006):797-802.
  12. Zhang M., et al. “Clinical characteristics of patients with dry eye syndrome”. Zhonghua Yan Ke Za Zhi 39.1 (2003): 5-9.
  13. Olami Y., et al. “Turnover and migration of meibomian gland cells in rats' eyelids”. Ophthalmic Research 33.3 (2001): 170-175.
  14. Josephson JE. “Appearance of preoculartear film lipid layer”. American Journal of Optometry and Physiological Optics 60.11 (1983): 883-887.
  15. Knopp E KN., et al. “The International Workshop on Meibomian Gland Dysfunction: Report of Subcommittee on Anatomy, Physiology, and Pathophysiology of the Meibomian gland”. Investigative Ophthalmology and Visual Science, Special 52.4 (2011): 1938-1978.
  16. Matsumoto Y DM., et al. “Efficacy of a new worm moist air device on tear functions of patients with simple meibomian gland dysfunction”. Cornea 25 (2006): 644-650.
  17. Mori A SJ., et al. “Disposable eyelid -worming device for treatment of meibomian gland dysfunction”. Japanese Journal of Ophthalmology 47 (2003): 578-586.
  18. Goto E SJ., et al. “Low concentration homogenized castor oil eye drops for noninflamed obstructive meibomian gland dysfunction”. Ophthalmology 109 (2002): 2030-2035.
  19. Blackie CA SJ., et al. “Inner eyelid surface temperature as a function of worm compress methodology”. Optometry and Vision Science (2008): 675-683.
  20. Goto E EK., et al. “Improvement of tear stability following worm compression in patients with meibomian gland dysfunction”. Advances in Experimental Medicine and Biology 506 (2002): 1149-1152.
  21. Ishida R MY., et al. “Tear film with "Orga-hexa EyeMasks"in patients with meibomien gland dysfunction”. Optometry and Vision Science 85 (2008): 684-691.
  22. Olson MC KD and Greiner JV. “Increase in tear film lipid layer thickness following treatment with worm worm compresses in patients with meibomian gland dysfunction”. Eye Contact Lens 29 (2003): 96-99.
  23. Hom MMSM. “Displacement technique and meibomian gland expression”. Journal of the American Optometric Association 58 (1987): 223-226.
  24. Duke-Elder WS MP. “The Ocular Adenexa. part 2: Diseases of the Eyelids”. London: H Kimpton (1974).
  25. Korb DR HA. “Meibomian gland dysfunction and contact lens intolerence”. Journal of the American Optometric Association 51 (1980): 243-251.
  26. Lane SS DH., et al. “A new system, the LipiFlow, for the treatment of meibomian gland dysfunction”. Cornea 31 (2012): 396-404.
  27. KorbDR B. “Casereport: asuccess ful Li pi flow treatment of a single case of meibomian gland dysfunction and dropout”. Eye Contact Lense (2003): 1-3.
  28. Savini G PP., et al. “The challenge of dry eye diagnosis”. Clinical Ophthalmology 2 (2008): 31-55.
  29. DR K. “The tear film: its role today and in the future. The Tear Film: Structure, Function and Clinical Examination”. Boston: Butterworth-Heinemann (2002): 9-13.
  30. DEWS. “The definitions and classification of dry eye disease: report of the Definition and Classification of the International Dry Eye Workshop”. The Ocular Surface (2007):133.
  31. Lemp MA HJ. “Factors affecting tear film break-up in normal eyes”. Arch Ophthalmology (1973): 103-105.
  32. Abelson M OG and Nally L. “Alternate reference value for tear film break-up time in normal and dry eye population”. Advances in Experimental Medicine and Biology (2002):1121-1125.
  33. Korb DR GJ and Hreman J. “Comparison of fluorescein break-up time measurement reproducibilty using standard fluorescein strips versus the Dry Eye Test (DET) method”.  Cornea (2001): 811-815.
  34. Milner MS BK and Luches JI. “Dysfunctional Tear Syndrome: Dry Eye Disease and Associated Tear Film Disorders”. New Strategies for Diagnosis and Treatment Current Openion in Ophthalmology (2017): 1-47.
  35. Shine WE MJ. “Keratoconjuctivitis sicca associated with meibomian secretion polar lipid abnormalitiy”. Archives of Ophthalmology 116 (1998): 849-852.
  36. Mather WD LJ. “Meibomian gland lipids, evaporation, and tear film stability”. Advances in Experimental Medicine and Biology 438 (1998): 349-360.
  37. Shine WE MJ. “Association of meibomian oleic acid with meibomian seborrhea”. Cornea 19 (2000): 72-74.
  38. Mathers WD SD., et al. “Menopause and tear function; the influence of prolactin and sex hormones on human tear production”. Cornea 17 (1998): 353-379.
  39. Foulks GN., et al. “Topical azithromycin therapy for meibomian gland dysfunction: clinical response and lipid alteration”. Cornea 29 (2010): 781-788.
  40. Finis D HJ., et al. “Evaluation of an automated thermodynamic treatment (Li pi Flow (R)) system for meibomian gland dysfunction: A prospective, randomized, observer-masked trial”. The Ocular Surface 12 (2014): 146-154.
  41. Baumann ACB. “Meibomian gland dysfunction: A comparative study of modern treatments [in French”. Journal Français D'Ophtalmologie 37 (2014): 137-142.
  42. M SPGSL. “Clinical Outcomes Associated with Thermal Pulsation System Treatment”. Optometry and Vision Science 92.9 9 (2015): 335-341.


Citation: Mohammed Abdelmaaboud Radwan., et al. “Efficacy of Thermo Mechanical Pulsations in Management of Meibomien Gland Dysfunction: A Comparative Study”.Acta Scientific Ophthalmology 3.2 (2020): 12-19.


Acceptance rate35%
Acceptance to publication20-30 days
ISI- IF1.042
JCR- IF0.24

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is June 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US